pentetic acid has been researched along with Thalassemia in 18 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Thalassemia: A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SMITH, RS | 1 |
| WEINER, M | 1 |
| Cerami, A | 2 |
| Grady, RW | 1 |
| Peterson, CM | 1 |
| Bhargava, KK | 1 |
| Ridley, CM | 1 |
| Arcasoy, A | 1 |
| Dogru, U | 1 |
| Cavdar, AO | 1 |
| Graziano, JH | 1 |
| Hershko, C | 2 |
| Graham, G | 1 |
| Bates, GW | 1 |
| Rachmilewitz, EA | 1 |
| Vullo, C | 1 |
| Di Palma, A | 1 |
| De Sanctis, V | 1 |
| Borgatti, L | 1 |
| Atti, G | 1 |
| Wonke, B | 1 |
| Hoffbrand, AV | 1 |
| Aldouri, M | 1 |
| Wickens, D | 1 |
| Flynn, D | 1 |
| Stearns, M | 1 |
| Warner, P | 1 |
| Pippard, MJ | 2 |
| Jackson, MJ | 2 |
| Modell, CB | 2 |
| Hoffman, K | 1 |
| Petrou, M | 1 |
| Beard, ME | 1 |
| Necheles, TF | 1 |
| Allen, DM | 1 |
| Constantoulakis, M | 1 |
| Economidou, J | 1 |
| Karagiorga, M | 1 |
| Katsantoni, A | 1 |
| Gyftaki, E | 1 |
| Barry, M | 1 |
| Flynn, DM | 1 |
| Letsky, EA | 1 |
| Risdon, RA | 1 |
| Stockman, JA | 1 |
| Oski, FA | 1 |
| Waxman, HS | 1 |
| Brown, EB | 1 |
| McDonald, R | 1 |
4 reviews available for pentetic acid and Thalassemia
| Article | Year |
|---|---|
Clinical management of thalassemia. The status of new iron chelators.
Topics: Animals; Chelating Agents; Chemical Phenomena; Chemistry; Cholic Acids; Deferoxamine; Drug Evaluatio | 1980 |
Chelation therapy for the treatment of thalassemia.
Topics: Chelating Agents; Deferoxamine; Humans; Hydroxamic Acids; Hydroxybenzoates; Pentetic Acid; Rhodotoru | 1977 |
[Iron-chelating treatment].
Topics: Chelation Therapy; Deferiprone; Deferoxamine; Erythropoiesis; Hemosiderosis; Humans; Iron; Iron Chel | 1989 |
Clinical usefulness of iron chelating agents.
Topics: Chelating Agents; Deferoxamine; Dimercaprol; Edetic Acid; Hemochromatosis; Humans; Iron; Iron Chelat | 1969 |
1 trial available for pentetic acid and Thalassemia
| Article | Year |
|---|---|
Long-term chelation therapy in thalassaemia major: effect on liver iron concentration, liver histology, and clinical progress.
Topics: Biopsy; Blood Transfusion; Chelating Agents; Child; Deferoxamine; Diethylamines; Female; Humans; Iro | 1974 |
13 other studies available for pentetic acid and Thalassemia
| Article | Year |
|---|---|
CHELATING AGENTS IN THE DIAGNOSIS AND TREATMENT OF IRON OVERLOAD IN THALASSEMIA.
Topics: Adolescent; Blood Transfusion; Chelating Agents; Child; Deferoxamine; Diagnosis; Drug Therapy; Human | 1964 |
FACTORS INFLUENCING THE CLINICAL USE OF CHELATES IN IRON STORAGE DISEASE.
Topics: Calcium; Chelating Agents; Chloramphenicol; Drug Therapy; Edetic Acid; Humans; Iron; Lymphoma, Non-H | 1964 |
Zinc deficiency developing in treatment for thalassaemia.
Topics: Child; Deferoxamine; Humans; Male; Pentetic Acid; Thalassemia; Transfusion Reaction; Zinc | 1982 |
Zinc deficiency in beta-thalassaemia.
Topics: Child; Humans; Pentetic Acid; Thalassemia; Zinc | 1982 |
Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity.
Topics: Adolescent; Adult; Blood Transfusion; Child; Chromatography, Ion Exchange; Electrophoresis, Polyacry | 1978 |
Pathogenesis and management of iron overload in thalassemia.
Topics: Deferoxamine; Hemochromatosis; Humans; Iron; Pentetic Acid; Thalassemia | 1975 |
Reversal of desferrioxamine induced auditory neurotoxicity during treatment with Ca-DTPA.
Topics: Adolescent; Adult; Audiometry; Blood Transfusion; Child; Child, Preschool; Deferoxamine; Female; Fer | 1989 |
Subcutaneous diethylene triamine pentaacetic acid: comparison with desferrioxamine in thalassemic patients with iron overload.
Topics: Adult; Child; Deferoxamine; Female; Humans; Infusions, Parenteral; Iron; Male; Pentetic Acid; Thalas | 1988 |
Iron chelation using subcutaneous infusions of diethylene triamine penta-acetic acid (DTPA).
Topics: Administration, Oral; Adult; Ascorbic Acid; Child; Deferoxamine; Dose-Response Relationship, Drug; D | 1986 |
Clinical experience with intensive transfusion therapy in Cooley's anemia.
Topics: 17-Ketosteroids; Blood Transfusion; Bone Development; Calcium; Child; Deferoxamine; Electrocardiogra | 1969 |
Combined long-term treatment of hemosiderosis with desferioxamine and DTPA in homozygous beta-thalassemia.
Topics: Adolescent; Adult; Blood Transfusion; Child; Deferoxamine; Drug Therapy, Combination; Erythrocytes; | 1974 |
Editorial: Thalassemia major: a problem of iron overload.
Topics: Ascorbic Acid; Chelating Agents; Child; Child, Preschool; Deferoxamine; Humans; Intestinal Absorptio | 1974 |
Deferoxamine and diethylenetriaminepentaacetic acid (DTPA) in thalassemia.
Topics: Child; Deferoxamine; Female; Humans; Infant; Iron; Male; Pentetic Acid; Thalassemia | 1966 |